Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of bisphosphonates on bone mineral density and bone turnover after surgery for primary hyperparathyroidism
2008-005405-20Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of zoledronic acid in primary hyperparathyroidism (PHPT) and osteoporosis, sponsored by Helsinki University Hospital. Primary endpoints: Bone mineral density and Bone turnover. Started Sep 2008; status: completed.
02
Drugs
zoledronic acid
03
Conditions
primary hyperparathyroidism (PHPT)osteoporosis
Beyond the preview
Go deeper on 2008-005405-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005405-20.